Nasogen (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasogen, is an alpha-adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children. GNH USA supplies Nasogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasogen, an alpha‑adrenergic nasal decongestant, is used to alleviate congestion in several upper‑respiratory conditions.

Common cold nasal congestion: reduces mucosal swelling to improve airflow. Sinusitis-associated congestion: decreases edema of the sinus passages. Allergic rhinitis: eases nasal blockage caused by allergic inflammation.

Adverse reactions may occur with nasal administration of Xylometazoline Hydrochloride.

Common Side Effects: - Nasal burning or stinging sensation - Dryness of the nasal mucosa - Sneezing - Headache - Altered taste or smell - Mild epistaxis

Serious or Rare Side Effects: - Rebound nasal congestion with prolonged use - Severe hypertension or tachycardia - Nasal ulceration or septal perforation - Allergic reaction (rash, itching, swelling) - Cardiac arrhythmia - Vision disturbances

Before using Nasogen, consider the following safety measures.

Use duration: limit use to 3‑5 consecutive days to avoid rebound congestion. Age restrictions: not recommended for children under 2 years unless directed by a clinician. Pregnancy: consult a healthcare professional before use. Cardiovascular disease: use with caution in patients with hypertension or heart disease. Concurrent nasal decongestants: avoid simultaneous use of other topical decongestants. Store at room temperature: keep in the original container, protect from moisture and heat.

Xylometazoline may interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstrictive effects. - Systemic sympathomimetics: excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: monitor for changes in heart rate or blood pressure.